Torthaí cuardaigh - Paul Baas

Beachtaigh na torthaí
  1. 1
    Malignant pleural mesothelioma

    Malignant pleural mesothelioma de réir Paul Baas, Hugo Schouwink, F.A.N. Zoetmulder

    Foilsithe / Cruthaithe 1998
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Current chemotherapy strategies in malignant pleural mesothelioma

    Current chemotherapy strategies in malignant pleural mesothelioma de réir Cornedine J. de Gooijer, Paul Baas, Jacobus A. Burgers

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Malignant pleural mesothelioma: The standard of care and challenges for future management

    Malignant pleural mesothelioma: The standard of care and challenges for future management de réir Jan P. van Meerbeeck, Arnaud Scherpereel, Veerle Surmont, Paul Baas

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy

    Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy de réir Enriqueta Felip, Cesare Gridelli, Paul Baas, Rafael Rosell, Rolf A. Stahel

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Photodynamic Therapy in Oncology

    Photodynamic Therapy in Oncology de réir Martijn Triesscheijn, Paul Baas, Jan H.M. Schellens, Fiona A. Stewart

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Immunotherapy in Malignant Pleural Mesothelioma

    Immunotherapy in Malignant Pleural Mesothelioma de réir Cornedine J. de Gooijer, Frank J. Borm, Arnaud Scherpereel, Paul Baas

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Second line therapy in malignant pleural mesothelioma: A systematic review

    Second line therapy in malignant pleural mesothelioma: A systematic review de réir Wieneke A. Buikhuisen, Birgitta I. Hiddinga, Paul Baas, Jan P. van Meerbeeck

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Foscan® uptake and tissue distribution in relation to photodynamic efficacy

    Foscan® uptake and tissue distribution in relation to photodynamic efficacy de réir P. Cramers, Marjan Ruevekamp, Hugo Oppelaar, Otilia Dalesio, Paul Baas, Fiona A. Stewart

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes

    A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outc... de réir Wieneke A. Buikhuisen, Marion Scharpfenecker, Arjan W. Griffioen, Catharina M. Korse, Harm van Tinteren, Paul Baas

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up de réir Paul Baas, Dean A. Fennell, Keith M. Kerr, Paul E. Van Schil, Rick L. Haas, Solange Peters

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    OA13.01 A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies

    OA13.01 A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies de réir Josine M.M.F. Quispel-Janssen, Giulia Zago, Robert D. Schouten, Wieneke A. Buikhuisen, Kim Monkhorst, E. Thunissen, Paul Baas

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010

    Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010 de réir Joannie Lortet‐Tieulent, Elisenda Rentería, Linda Sharp, Elisabete Weiderpass, Harry Comber, Paul Baas, Freddie Bray, J.W.W. Coebergh, Isabelle Soerjomataram

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

    Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study de réir Paul Baas, J. Belderbos, Suresh Senan, H Kwa, Aart van Bochove, Harm van Tinteren, J.A. Burgers, Jan P. van Meerbeeck

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ de réir Sanjay Popat, Paul Baas, Corinne Faivre‐Finn, Nicolas Girard, Andrew G. Nicholson, Anna K. Nowak, Isabelle Opitz, Arnaud Scherpereel, Martin Reck

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies

    Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies de réir Paul Baas, L. Murrer, F.A.N. Zoetmulder, FA Stewart, Hans‐Beat Ris, Nico van Zandwijk, J. L. Peterse, Emiel J. Rutgers

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Photodynamic therapy: a promising new modality for the treatment of cancer

    Photodynamic therapy: a promising new modality for the treatment of cancer de réir J. J. Schuitmaker, Paul Baas, H.L.L.M. van Leengoed, Freerk W. van der Meulen, Willem M. Star, Nico van Zandwijk

    Foilsithe / Cruthaithe 1996
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Relationship Between Cisplatin Administration and the Development of Ototoxicity

    Relationship Between Cisplatin Administration and the Development of Ototoxicity de réir Jeany M. Rademaker-Lakhai, Mirjam Crul, Lot C. Zuur, Paul Baas, Jos H. Beijnen, Yvonne J. Simis, Nico van Zandwijk, Jan H.M. Schellens

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patients

    Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patients de réir Markus Joerger, Alwin D. R. Huitema, H.J.G.D. van den Bongard, Paul Baas, Jan H. Schornagel, Jan H.M. Schellens, Jos H. Beijnen

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

    EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer de réir Nico van Zandwijk, Alexandre Mathy, Lucie Boerrigter, Henrique J. Ruijter, Ivon H. G. Tielen, Daniëlle de Jong, Paul Baas, Sjaak A. Burgers, Petra M. Nederlof

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

    A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chem... de réir Robert A. Belderbos, Paul Baas, Rossana Berardi, Robin Cornelissen, Dean A. Fennell, Jan P. van Meerbeeck, Arnaud Scherpereel, Heleen Vroman, Joachim G.J.V. Aerts

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: